Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Critical reviews in microbiology

• Publication date

  2015-07-03

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3109/1040841X.2013.847898PMID 24645634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two quorum sensing systems control biofilm formation and virulence in members of the Burkholderia cepacia complex

  2013cited by this paper
• The cystic fibrosis airway microbiome.

  2013cited by this paper
• High rhinovirus burden in lower airways of children with cystic fibrosis.

  2013influential reference
• Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa.

  2013cited by this paper
• Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.

  2013cited by this paper
• Antibiotic and anti-inflammatory therapies for cystic fibrosis.

  2013cited by this paper
• Cystic fibrosis therapy: a community ecology perspective.

  2013influential reference
• Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.

  2012cited by this paper
• Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species.

  2012cited by this paper
• High prevalence of Pneumocystis jirovecii colonization in Brazilian cystic fibrosis patients.

  2012cited by this paper
• The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management

  2012cited by this paper
• Atypical Bacteria in the CF Airways: Diversity, Clinical Consequences, Emergence and Adaptation

  2012cited by this paper
• ntibiotic resistance of mixed biofilms in cystic fibrosis : impact of emerging icroorganisms on treatment of infection usana

  2012cited by this paper
• Viral infections trigger exacerbations of cystic fibrosis in adults and children

  2012cited by this paper
• A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients.

  2012cited by this paper
• Decade-long bacterial community dynamics in cystic fibrosis airways

  2012cited by this paper
• Treatment of lung infection in patients with cystic fibrosis: current and future strategies.

  2012cited by this paper
• Polymicrobial Interactions: Impact on Pathogenesis and Human Disease

  2012cited by this paper
• Cystic fibrosis.

  2012cited by this paper
• Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung.

  2012cited by this paper
• Bacteriophages as vehicles of the resistome in cystic fibrosis.

  2011cited by this paper
• Microbial ecology and adaptation in cystic fibrosis airways.

  2011cited by this paper
• Virulence of an emerging respiratory pathogen, genus Pandoraea, in vivo and its interactions with lung epithelial cells.

  2011cited by this paper
• Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota.

  2011cited by this paper
• Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis

  2011influential reference
• Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa

  2011cited by this paper
• Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

  2011influential reference
• Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention

  2011cited by this paper
• in Patients With Cystic Fibrosis

  2011cited by this paper
• Bacterial-Fungal Interactions: Hyphens between Agricultural, Clinical, Environmental, and Food Microbiologists

  2011cited by this paper
• Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis

  2011influential reference
• Geosmithia argillacea: an Emerging Pathogen in Patients with Cystic Fibrosis

  2010cited by this paper
• The Changing Microbial Epidemiology in Cystic Fibrosis

  2010cited by this paper
• Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis

  2010cited by this paper
• Outbreak of Corynebacterium pseudodiphtheriticum Infection in Cystic Fibrosis Patients, France

  2010cited by this paper
• Rhinovirus C and Respiratory Exacerbations in Children with Cystic Fibrosis

  2010cited by this paper
• Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients

  2010cited by this paper
• Pneumocystis jirovecii and cystic fibrosis in France

  2010cited by this paper
• Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients

  2010cited by this paper
• A Decade of Burkholderia cenocepacia Virulence Determinant Research

  2010cited by this paper
• Pseudomonas aeruginosa biofilms in cystic fibrosis.

  2010influential reference
• Bacteriophage‐derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa

  2010cited by this paper
• Pseudomonas aeruginosa secreted factors impair biofilm development in Candida albicans.

  2010cited by this paper
• Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients.

  2010cited by this paper
• Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

  2010cited by this paper
• First report of Paenibacillus cineris from a patient with cystic fibrosis.

  2010cited by this paper
• Wide Host Range and Strong Lytic Activity of Staphylococcus aureus Lytic Phage Stau2

  2010cited by this paper
• Isolation of the Fungus Geosmithia argillacea in Sputum of People with Cystic Fibrosis

  2010cited by this paper
• Antibiotic resistance of bacterial biofilms.

  2010cited by this paper
• Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation.

  2010cited by this paper
• Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity

  2010cited by this paper
• Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient

  2010cited by this paper
• Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.

  2010cited by this paper
• Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.

  2010cited by this paper
• Sputum Candida albicans presages FEV₁ decline and hospital-treated exacerbations in cystic fibrosis.

  2010cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Airway Infection with a Novel Cupriavidus Species in Persons with Cystic Fibrosis

  2009cited by this paper
• Preventing biofilms of clinically relevant organisms using bacteriophage.

  2009cited by this paper
• Detection of Occult Scedosporium Species in Respiratory Tract Specimens from Patients with Cystic Fibrosis by Use of Selective Media

  2009cited by this paper
• Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

  2009cited by this paper
• Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage

  2009cited by this paper
• Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients

  2009cited by this paper
• The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.

  2009cited by this paper
• Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.

  2009cited by this paper
• Trichosporon mycotoxinivorans, a Novel Respiratory Pathogen in Patients with Cystic Fibrosis

  2009cited by this paper
• Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals

  2009cited by this paper
• Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients

  2008influential reference
• A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

  2008cited by this paper
• First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report

  2008cited by this paper
• Development of an Oligonucleotide Array for Direct Detection of Fungi in Sputum Samples from Patients with Cystic Fibrosis

  2008cited by this paper
• Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.

  2008cited by this paper
• Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

  2008cited by this paper
• The role of respiratory viruses in cystic fibrosis

  2008cited by this paper
• Nutritional Cues Control Pseudomonas aeruginosa Multicellular Behavior in Cystic Fibrosis Sputum

  2007cited by this paper
• Immunostimulatory Properties of the Emerging Pathogen Stenotrophomonas maltophilia

  2007cited by this paper
• Emergence of Scedosporium apiospermum in patients with cystic fibrosis

  2007cited by this paper
• In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections

  2007cited by this paper
• Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

  2007cited by this paper
• Evolution of species interactions in a biofilm community

  2007cited by this paper
• Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.

  2007cited by this paper
• Antifungal Susceptibilities of the Species of the Pseudallescheria boydii Complex

  2006cited by this paper
• Cystic fibrosis: a polymicrobial infectious disease.

  2006cited by this paper
• Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa

  2006cited by this paper
• Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic

  2006influential reference
• Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis.

  2006cited by this paper
• Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients.

  2006cited by this paper
• Airway Colonization by Acrophialophora fusispora in Patients with Cystic Fibrosis

  2005cited by this paper
• Infection and inflammation in cystic fibrosis: a short review.

  2005cited by this paper
• Age-Related Prevalence and Distribution of Nontuberculous Mycobacterial Species among Patients with Cystic Fibrosis

  2005cited by this paper
• Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms

  2004cited by this paper
• Isolation of Fungi, Especially Exophiala dermatitidis, in Patients Suffering from Cystic Fibrosis

  2004cited by this paper
• Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum.

  2004cited by this paper
• Infection Control in Cystic Fibrosis

  2004cited by this paper
• Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling

  2004cited by this paper
• Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis

  2004cited by this paper
• Relationship of airway epithelial ion transport to chronic bronchitis.

  2004cited by this paper
• Laboratory Aspects of Management of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

  2003cited by this paper
• Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication

  2003cited by this paper
• Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis

  2003cited by this paper
• Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism Profiling

  2003cited by this paper

• Identification of PilD mutants reveals the iterative social evolution in Pseudomonas aeruginosa

  2025cites this paper
• Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis

  2022cites this paper
• Respiratory Viruses and Cystic Fibrosis

  2022cites this paper
• Experimental systems biology approaches reveal interaction mechanisms in model multispecies communities.

  2021cites this paper
• Genome evolution drives transcriptomic and phenotypic adaptation in Pseudomonas aeruginosa during 20 years of infection

  2021cites this paper
• The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi

  2020cites this paper
• Antibiofilm activities of ceragenins and antimicrobial peptides against fungal-bacterial mono and multispecies biofilms

  2020cites this paper
• Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy

  2020cites this paper
• Pseudomonas aeruginosa: Diseases, Biofilm and Antibiotic Resistance

  2020cites this paper
• Microbial biosurfactants: current trends and applications in agricultural and biomedical industries

  2019cites this paper
• Engineering mucus to study and influence the microbiome

  2019cites this paper
• Quantitative assessment of individual populations within polymicrobial biofilms

  2018cites this paper
• Bacterial-fungal interactions: ecology, mechanisms and challenges.

  2018cites this paper
• Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis

  2017cites this paper
• Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Cystic Fibrosis Patients from Argentina

  2017cites this paper
• Viruses in cystic fibrosis patients’ airways

  2017cites this paper
• Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress.

  2017cites this paper
• Impact of polymicrobial biofilms in catheter-associated urinary tract infections

  2017cites this paper
• Biofilms: Survival and defense strategy for pathogens.

  2017cites this paper
• Impact of Delftia tsuruhatensis and Achromobacter xylosoxidans on Escherichia coli dual-species biofilms treated with antibiotic agents

  2016cites this paper
• Discriminating typical and atypical cystic fibrosis‐related bacteria by multiplex PNA‐FISH

  2016influential citation
• Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections

  2016cites this paper
• Gram-negative bacteria in cystic fibrosis

  2015influential citation
• Antibacterial and Biophysical Characterization of Nitric Oxide-Releasing Chitosan Oligosaccharides – Towards a New Cystic Fibrosis Therapeutic

  2015cites this paper
• The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy

  2015cites this paper
• Effect of Algae and Plant Lectins on Planktonic Growth and Biofilm Formation in Clinically Relevant Bacteria and Yeasts

  2014cites this paper
• Interaction between atypical microorganisms and E. coli in catheter-associated urinary tract biofilms

  2014cites this paper
• Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment

  2014cites this paper
• Emergent Bacteria in Cystic Fibrosis: In Vitro Biofilm Formation and Resilience under Variable Oxygen Conditions

  2014cites this paper